Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial
Background Cardiac biomarkers and left ventricular hypertrophy (LVH) are related to the risk of stroke and death in patients with atrial fibrillation. We investigated the interrelationship between LVH and cardiac biomarkers and their independent associations with outcomes. Methods and Results Plasma...
| المؤلفون الرئيسيون: | , , , , , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
Wiley
2019-01-01
|
| سلاسل: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.ahajournals.org/doi/10.1161/JAHA.118.010107 |